You have 9 free searches left this month | for more free features.

City

Atlanta (1)

Brooklyn (1)

Ibadan (1)

Kano (1)

Lagos (1)

New York (1)

Ocala (1)

Vancouver (1)

Condition

Sickle Cell Disease (2)

Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R (1)

Overall Status

Recruiting (2)

Not yet recruiting (1)

Sign in for free

Phase

phase 2 (3)

Sponsor

Forma Therapeutics, Inc. (2)

Novo Nordisk A/S (1)

Collaborator

Emory University (1)

Intervention

etavopivat (3)

hydroxyurea (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

etavopivat

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Sickle Cell Disease Trial in Atlanta (Etavopivat)

Not yet recruiting

Sickle Cell Disease

Etavopivat

Atlanta, Georgia

Emory University Children's Healthcare of Atlanta

Feb 10, 2023

Sickle Cell Disease Trial in Ibadan, Kano, Lagos (Etavopivat, Hydroxyurea)

Recruiting

Sickle Cell Disease

Etavopivat
Hydroxyurea

Ibadan, Nigeria
+2 more

Jul 12, 2023

Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R Trial in Canada, United States (Etavopivat)

Recruiting

Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R

Etavopivat

Ocala, Florida
+3 more

Jan 30, 2023